GMO Beyond China ETF
BCHI
5 hedge funds and large institutions have $2.26M invested in GMO Beyond China ETF in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $1.91M → $2.26M (+$352K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
1.47% less ownership
Funds ownership: 15.67% → 14.2% (-1.5%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$302K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HC
Hara Capital
Bellevue,
Washington
|
-$14.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.6K |
BCHI Hedge Fund Activity: Q1 2026 in Review
5 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q1 2026, worth a combined $2.26M — up 18% from $1.91M a quarter earlier.
Fund positioning in BCHI was balanced in Q1 2026: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $302K. The largest seller was Hara Capital, cutting an estimated $14.4K.
- 5 institutional investors held GMO Beyond China ETF (BCHI) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $2.26M of GMO Beyond China ETF stock for Q1 2026, up 18% quarter-over-quarter.
- 1 fund opened new GMO Beyond China ETF positions in Q1 2026 and 1 closed out, a net change of 0 holders.
- The largest GMO Beyond China ETF buyer in Q1 2026 was Jane Street, an estimated $302K added.
- The largest GMO Beyond China ETF seller in Q1 2026 was Hara Capital, an estimated $14.4K sold.
Based on aggregated 13F filings for Q1 2026.